Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

AbbVie Stock Falls Below Key 50-Day and 200-Day Moving Averages: Strategies for Investors - The Globe and Mail

17 Apr, 2026

Comparing High Yield and Sustainable Growth: The Reasons AbbVie's Dividend Outshines Pfizer's Even with a Smaller Distribution

06 Apr, 2026

What Impact Will Skyrizi and Rinvoq Have on AbbVie's Immunology Sales in Q1? - TradingView

06 Apr, 2026

Exchange Traded Concepts Increases Its Investment in AbbVie by 150% - North Chicago Today

28 Mar, 2026

See More